Skip to main content
. 2014 Jun;58(6):3306–3311. doi: 10.1128/AAC.01920-13

FIG 4.

FIG 4

Predicted in vivo mycobactericidal activity of U-603 and U-480, individually and in combination, after simulated oral dosing with sutezolid at 600 mg BID and 1,200 mg QD. (Top) Activity at discrete time points; (bottom) cumulative activity, calculated as the integral over time of values at discrete time points. Shading indicates the 90% CI on the basis of PK variability.